Vivesto is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers.
Regulatory May 25, 2023Report from Annual General Meeting in Vivesto AB
Regulatory May 25, 2023Interim report for the period January 2023 – March 2023
Regulatory April 25, 2023Notice of Annual General Meeting in Vivesto AB
Vivesto published its Q1 report for 2023 on May 25, 2023, at 08.00 am CEST.